We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

SR Pharma Announces Completion of Additional Toxicology Studies for its Systemically Delivered RNAi Compound

News   Jan 30, 2007

 
SR Pharma Announces Completion of Additional Toxicology Studies for its Systemically Delivered RNAi Compound
 
 
 

RELATED ARTICLES

Why Not Catching Enough Zzz’s Is Bad for Your Heart

News

In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.

READ MORE

Timing Is Key in Cell Protein Production

News

Scientists at the University of Sheffield have discovered how genes create proteins in research which could aid the development of treatments for human diseases.

READ MORE

More Effective Drug Combination Regimens to Treat TB Faster

News

UCLA researchers have identified a way to significantly reduce the duration of tuberculosis treatment using an approach called "artificial intelligence-parabolic response surface."

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE